RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
7.93
-0.11 (-1.37%)
At close: Apr 18, 2024, 4:00 PM
8.00
+0.07 (0.88%)
Pre-market: Apr 19, 2024, 9:01 AM EDT
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $275.95 million as of April 19, 2024. Its market cap has decreased by -50.16% in one year.
Market Cap
275.95M
Enterprise Value
123.99M
1-Year Change
-50.16%
Ranking
Category
Stock Price
$7.93
Market Cap Chart
Since November 1, 2019, RAPT Therapeutics's market cap has increased from $270.30M to $275.95M, an increase of 2.09%. That is a compound annual growth rate of 0.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 275.90M | -1.39% |
Apr 17, 2024 | 279.80M | -1.10% |
Apr 16, 2024 | 282.90M | -4.81% |
Apr 15, 2024 | 297.20M | -7.07% |
Apr 12, 2024 | 319.80M | -2.02% |
Apr 11, 2024 | 326.40M | 3.98% |
Apr 10, 2024 | 313.90M | 6.88% |
Apr 9, 2024 | 293.70M | 1.45% |
Apr 8, 2024 | 289.50M | 5.31% |
Apr 5, 2024 | 274.90M | -1.36% |
Apr 4, 2024 | 278.70M | -4.19% |
Apr 3, 2024 | 290.90M | 1.82% |
Apr 2, 2024 | 285.70M | -2.82% |
Apr 1, 2024 | 294.00M | -5.92% |
Mar 28, 2024 | 312.50M | 0.58% |
Mar 27, 2024 | 310.70M | 6.29% |
Mar 26, 2024 | 292.30M | 1.56% |
Mar 25, 2024 | 287.80M | -0.72% |
Mar 22, 2024 | 289.90M | -2.09% |
Mar 21, 2024 | 296.10M | -1.95% |
Mar 20, 2024 | 302.00M | 0.43% |
Mar 19, 2024 | 300.70M | 3.73% |
Mar 18, 2024 | 289.90M | -1.63% |
Mar 15, 2024 | 294.70M | 0.72% |
Mar 14, 2024 | 292.60M | -2.01% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Opthea | 279.97M |
XOMA Corporation | 279.25M |
XBiotech | 278.50M |
Verastem | 278.25M |
Sanara MedTech | 278.04M |
Ventyx Biosciences | 275.82M |
EDAP TMS | 274.57M |
Fennec Pharmaceuticals | 270.46M |